Study & Fleet Management
Streamlined workflows allow study coordinators to pair bracelets, track battery status, manage gateway connections, and monitor patient wear-compliance in real time across global multi-site trials.
Accelerating Trial Innovation
Medical-Grade Continuous Monitoring for Decentralised Clinical Trials
Corsano’s CardioWatch 287 wrist-worn multi-sensor bracelet enables continuous collection of high-density physiological data. Designed for decentralized clinical trials (DCTs) and long-term observational studies, the platform bridges the gap between clinical settings and home environments while preserving data integrity and regulatory compliance.
Incorporating continuous wearable sensors into study protocols overcomes traditional clinical trial bottlenecks—including patient retention, sporadic observation gaps, and subjective endpoint reporting. By continuously logging up to 19 vital parameters, researchers receive robust, longitudinal datasets that reflect real-world patient health status.
Engineered under ISO 13485 quality standards with CE-MDR certification and FDA 510(k) clearance, CardioWatch provides pharmaceutical sponsors, CROs, and academic investigators with clinically validated measurements suitable for secondary endpoints, safety monitoring, and exploratory digital biomarker discovery.
- Enhanced Patient Retention & EngagementLightweight ergonomic bracelet designed for 24/7 wearability up to 15 days per charge, minimizing participant burden.
- Uninterrupted Continuous Data StreamContinuous monitoring in hospital wards and post-discharge home settings without requiring manual data entry.
- Real-Time Safety & Early Event DetectionAutomated anomaly detection alerts study teams to early physiological shifts, ensuring timely intervention and subject safety.
Data Control & Analytics
Centralised Cloud Research Portal & Fleet Management
The Corsano Research Portal provides clinical trial investigators and study nurses with total administrative control over device fleets, subject onboarding, data sampling configurations, and protocol compliance tracking.
Automated Quality Auditing
Inbound physiological signals are automatically evaluated for data quality, motion artifacts, and signal plausibility, backed by an immutable log trail to guarantee auditability for regulatory submissions.
Unrestricted Raw Signal Access
Export uncompressed raw signals—including Green, Red, and Infrared PPG, single-lead ECG rhythm, 3-axis Accelerometer, GSR, and Skin Temperature—at sampling rates up to 128 Hz.
Granular Flexibility
Custom Sampling Frequencies & Algorithm Integration
Unlike consumer wearables with black-box proprietary algorithms, Corsano offers open access to raw data streams. Researchers can execute proprietary machine learning models, test digital biomarkers, or integrate external algorithm pipelines.
| Parameter Category | Measured / Derived Vital Signs | Sampling Frequencies & Export Formats |
|---|---|---|
| Cardiovascular | Heart Rate (HR), Inter-Beat-Intervals (RR Intervals), Single-lead ECG, PPG Waveforms (Green/Red/IR), AFib Risk | 1 Hz derived trends up to 128 Hz raw signal export (CSV, JSON, REST API) |
| Respiratory & Oxygenation | Continuous Respiration Rate (RR), Pulse Oximetry (SpO2) | Configurable intervals by minute, second, or continuous high-frequency capture |
| Thermal & Electrodermal | Core-Body Skin Temperature, Galvanic Skin Response (GSR) | High-resolution thermal sampling for infection and stress monitoring |
| Kinematics & Sleep | 3-Axis Accelerometer, Activity Count, Posture, Sleep Architecture Staging | 25 Hz to 128 Hz accelerometer raw signal access |
Featured Clinical Research
Research Case Study: Congestion Phenotypes in Chronic Heart Failure
Corsano actively participates in over 30 global cardiovascular and oncology trials. A flagship collaboration includes a major investigation at Duke Heart Center focusing on congestion phenotyping in chronic heart failure (HF) patients.
During right heart catheterization and 6-minute walk tests, CardioWatch 287 captures multi-wavelength PPG signals alongside gold-standard invasive arterial line measurements. The trial aims to map intra-vascular versus extra-vascular fluid redistribution, establishing non-invasive digital biomarkers for personalized decongestive therapies.
Gold-Standard Validation
Correlating continuous wearable optical and kinematic metrics with invasive hemodynamic reference markers in chronic heart failure cohorts.
AI & Biomarker Discovery
Generating high-fidelity datasets suitable for machine learning training models to predict decompensation prior to clinical hospitalization.
Conduct Your Next Clinical Trial with Corsano
Speak with our clinical data specialists to discuss protocol requirements, custom parameter configurations, research API integrations, or sample hardware evaluation for your study team.
Inquire NowFeature availability and regulatory clearance status may vary by country or region. Please consult with our compliance team regarding local regulatory approvals for specific clinical research applications.